Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
In glaucoma, studies revealed an involvement of the complement system. In an experimental autoimmune glaucoma model, immunization with an optic nerve homogenate antigen (ONA) led to retinal ganglion cell (RGC) loss, while intraocular pressure (IOP) remained unchanged. Here, we investigated the thera...
Saved in:
Main Authors: | Sabrina Reinehr (Author), Sara C. Gomes (Author), Caroline J. Gassel (Author), M. Ali Asaad (Author), Gesa Stute (Author), Marc Schargus (Author), H. Burkhard Dick (Author), Stephanie C. Joachim (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal Administration of rhNGF Enhances Regenerative Processes in a Zebrafish Model of Retinal Degeneration
by: Pasquale Cocchiaro, et al.
Published: (2022) -
Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
by: Raphael Mietzner, et al.
Published: (2020) -
The Comparative Efficiency of Intraperitoneal and Intravitreous Injection of Hydrogen Rich Saline against N-Methyl-N-Nitrosourea Induced Retinal Degeneration: A Topographic Study
by: Ye Tao, et al.
Published: (2017) -
Retinal changes in an ATP-induced model of retinal degeneration
by: Felix Peter Aplin, et al.
Published: (2016) -
Intravitreal Bevacizumab Injection Effect in Exudative Age Related Macular Degeneration
by: Gholamhossein Yaghoobi, et al.
Published: (2016)